Research Use Only - Not for human consumption. 18+ only.
AGrade ALarge human randomised controlled trials or FDA/major-authority approvedFDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indicationCardiovascular HealthSubcutaneous

Natriuretic Peptides (BNP, ANP)

Also known as: B-type Natriuretic Peptide (BNP), Atrial Natriuretic Peptide (ANP), N-terminal pro-BNP (NT-proBNP), Nesiritide (recombinant BNP)

Endogenous peptides that regulate blood pressure, fluid balance, and cardiac function. Researched for heart failure and hypertension management.

Research Status

AGrade ALarge human randomised controlled trials or FDA/major-authority approvedFDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indication

Clinical trials

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces blood pressure and systemic vascular resistance
Promotes sodium and water excretion
Decreases cardiac preload and afterload
Inhibits renin-angiotensin-aldosterone system
Reduces cardiac fibrosis and remodeling
Improves exercise tolerance in heart failure
Decreases sympathetic nervous system activity

Side Effects

Hypotension
CommonModerate

Significant blood pressure reduction is the primary pharmacological effect. Requires continuous monitoring during IV infusion. May limit dose escalation. Symptomatic hypotension (dizziness, syncope) can occur.

Headache
CommonMild

Often related to hypotension. Usually resolves with dose adjustment or fluid management.

Renal dysfunction
UncommonModerate

Paradoxical worsening of renal function has been reported in some heart failure patients, particularly with aggressive diuresis. Monitor serum creatinine and electrolytes closely.

Hypokalemia
UncommonModerate

Increased urinary potassium excretion can lead to low serum potassium. Monitor electrolytes and supplement as needed.

Hyponatremia
UncommonModerate

Excessive sodium excretion and water retention can lower serum sodium. More common with prolonged infusions.

Tachycardia
UncommonMild

Reflex tachycardia may occur in response to hypotension. Usually mild and self-limited.

Arrhythmias
RareSerious

Electrolyte abnormalities (hypokalemia, hyponatremia) can predispose to arrhythmias. Continuous cardiac monitoring is essential.

Allergic reaction
RareSerious

Hypersensitivity reactions including rash, angioedema, or anaphylaxis are rare but possible. Discontinue immediately if suspected.

Azotemia
UncommonModerate

Elevation in blood urea nitrogen may occur, particularly in volume-depleted patients. Monitor renal function parameters.

Dosing Reference

ParameterValue
Dose range0.01-0.1 mcg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weightANP: 3,067 Da; BNP: 3,464 Da
Half-lifeANP: 2-3 minutes; BNP: 15-20 minutes
SequenceMembers only

Natriuretic peptides (ANP and BNP) are endogenous hormones that bind to natriuretic peptide receptors (NPR-A and NPR-B) on vascular smooth muscle, endothelial cells, and renal tissue. This activation increases intracellular cyclic GMP, leading to vasodilation, reduced cardiac preload and afterload, increased sodium and water excretion, and inhibition of the renin-angiotensin-aldosterone system (RAAS). These coordinated effects lower blood pressure, reduce cardiac workload, and improve cardiac function in heart failure.

Pathways and mechanism detail available to members

Track your Natriuretic Peptides (BNP, ANP) research

Free account. No credit card required.

Start Free

Recent Research

All results

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Natriuretic Peptides (BNP, ANP) is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.